KWANG DONG PHARMACEUTICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6,840 KRW | +0.88% |
|
+1.18% | -7.94% |
| Sales 2022 | 1,432B 1.04B 1.42B | Sales 2023 | 1,514B 1.1B 1.51B | Capitalization | 298B 217M 296M |
|---|---|---|---|---|---|
| Net income 2022 | 24.17B 17.6M 24.03M | Net income 2023 | 36.97B 26.91M 36.74M | EV / Sales 2022 | 0.12 x |
| Net cash position 2022 | 70.63B 51.42M 70.2M | Net Debt 2023 | 29.46B 21.45M 29.28M | EV / Sales 2023 | 0.22 x |
| P/E ratio 2022 |
10.1
x | P/E ratio 2023 |
8.14
x | Employees | 1,024 |
| Yield 2022 |
1.68% | Yield 2023 |
1.35% | Free-Float | 58.04% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.88% | ||
| 1 week | +1.18% | ||
| Current month | -5.91% | ||
| 1 month | -5.91% | ||
| 3 months | -4.34% | ||
| 6 months | -2.29% | ||
| Current year | -7.94% |
1 week
6 700.00
6 910.00
1 month
6 510.007 380.00
Current year
6 510.008 500.00
1 year
5 750.008 500.00
3 years
5 370.009 900.00
5 years
3 910.0013 350.00
10 years
3 910.0019 100.00
| Managers | Title | Age | Since |
|---|---|---|---|
Sung-Won Choi
CEO | Chief Executive Officer | 54 | - |
Chae-Ju Lee
BRD | Director/Board Member | 52 | - |
Sang-Young Park
BRD | Director/Board Member | 61 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Sung-Won Choi
CEO | Chief Executive Officer | 54 | - |
Shin-Il Yeom
BRD | Director/Board Member | 50 | 20-03-19 |
Sang-Young Park
BRD | Director/Board Member | 61 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-29 | 6,840 | +0.88% | 120,160 |
| 24-04-26 | 6,780 | +0.44% | 55,587 |
| 24-04-25 | 6,750 | -0.30% | 104,203 |
| 24-04-24 | 6,770 | 0.00% | 61,381 |
| 24-04-23 | 6,770 | +0.15% | 106,657 |
End-of-day quote Korea S.E., April 28, 2024
More quotes
Kwangdong Pharmaceutical Co Ltd is a Korea-based company principally engaged in the manufacturing and distribution of pharmaceuticals. The Company operates its business through five segments. The Mineral Water Business segment supplies drinking spring water under Samdasoo brand. The Distribution Business segment distributes health drinks under brand names of Vita500 and Corn Silk Tea. The Pharmacy Business segment provides Chinese prescription cold medicines, hypertension medicines, cerebral apoplexy medicines and health drinks. The Hospital Business segment offers anticancer agents, blood vessel adjuvants, vitamin D injections and others. The Other segment provides products which not covered by Pharmacy, Hospital and Distribution segments.
Sector
Pharmaceuticals
Calendar
2024-05-12
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -7.94% | 197M | |
| +20.81% | 43.34B | |
| +20.93% | 21.96B | |
| +13.30% | 14.09B | |
| +12.97% | 13.64B | |
| +39.74% | 11.43B | |
| -11.23% | 6.86B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +9.64% | 5.22B |
- Stock Market
- Equities
- A009290 Stock
